Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrice Larosa

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Experimental Hematology & Oncology|April 16, 2016
Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignanciesClémentine Gamonet, Elodie Bole-Richard, Aurélia Delherme, et al.
Transfusion|July 29, 2010
Persistence of lymphocyte function perturbations after granulocyte-colony-stimulating factor mobilization and cytapheresis in normal peripheral blood stem cell donorsCaroline Marmier-Savet, Fabrice Larosa, Faezeh Legrand, et al.
Experimental Hematology & Oncology|March 4, 2016
New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignanciesClémentine Gamonet, Elodie Bole-Richard, Aurélia Delherme, et al.
Journal of Clinical Microbiology|March 23, 2018
Clinical Assessment of a Nocardia PCR-Based Assay for Diagnosis of NocardiosisClaire Rouzaud, Véronica Rodriguez-Nava, Emilie Catherinot, et al.
Cancer Research|December 6, 2018
CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T CellsWalid Warda, Fabrice Larosa, Mathieu Neto Da Rocha, et al.
Haematologica|October 26, 2010
A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 studyMathilde Hunault-Berger, Thibaut Leguay, Xavier Thomas, et al.
European Journal of Haematology|January 26, 2017
Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemiaXavier Cahu, Martin Carré, Christian Recher, et al.
Haematologica|January 19, 2010
Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie CellulaireAlice Garnier, Marie Robin, Fabrice Larosa, et al.
Leukemia Research|February 14, 2015
The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcomeWei W Chien, Régine Catallo, Amel Chebel, et al.
Bone Marrow Transplantation|October 31, 2019
Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donorClémence Deteix, Florence Mesnil, Sabine Furst, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Experimental Hematology & Oncology|April 16, 2016
Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignanciesClémentine Gamonet, Elodie Bole-Richard, Aurélia Delherme, et al.
Transfusion|July 29, 2010
Persistence of lymphocyte function perturbations after granulocyte-colony-stimulating factor mobilization and cytapheresis in normal peripheral blood stem cell donorsCaroline Marmier-Savet, Fabrice Larosa, Faezeh Legrand, et al.
Experimental Hematology & Oncology|March 4, 2016
New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignanciesClémentine Gamonet, Elodie Bole-Richard, Aurélia Delherme, et al.
Journal of Clinical Microbiology|March 23, 2018
Clinical Assessment of a Nocardia PCR-Based Assay for Diagnosis of NocardiosisClaire Rouzaud, Véronica Rodriguez-Nava, Emilie Catherinot, et al.
Cancer Research|December 6, 2018
CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T CellsWalid Warda, Fabrice Larosa, Mathieu Neto Da Rocha, et al.
Haematologica|October 26, 2010
A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 studyMathilde Hunault-Berger, Thibaut Leguay, Xavier Thomas, et al.
European Journal of Haematology|January 26, 2017
Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemiaXavier Cahu, Martin Carré, Christian Recher, et al.
Haematologica|January 19, 2010
Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie CellulaireAlice Garnier, Marie Robin, Fabrice Larosa, et al.
Leukemia Research|February 14, 2015
The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcomeWei W Chien, Régine Catallo, Amel Chebel, et al.
Bone Marrow Transplantation|October 31, 2019
Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donorClémence Deteix, Florence Mesnil, Sabine Furst, et al.
Pageof 4